Literature DB >> 7426272

Theophylline kinetics in relation to age: the importance of smoking.

B Cusack, J G Kelly, J Lavan, J Noel, K O'Malley.   

Abstract

1 Single dose studies of theophylline kinetics were compared in groups of young and elderly smokers and non-smokers to assess the effect of age on theophylline absorption and the effect of smoking on drug metabolising enzyme activity in old age. 2 The rate and extent of absorption was not affected by age. Distribution and elimination kinetics were similar in young and elderly non-smokers. 3 In young subjects the elimination half-life of theophylline was shorter and clearance was significantly greater in smokers than in non-smokers. 4 In the elderly mean elimination half-life was significantly shorter in smokers and their plasma clearance was 40% higher than in non-smokers. The statistical difference for clearance was at the 7% level of significance. 5 These data indicate that ageing per se does not affect theophylline elimination and also that induction of theophylline metabolism due to smoking occurs in old age. Smoking is a variable that should be taken account of when assessing drug metabolism in elderly patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7426272      PMCID: PMC1430051          DOI: 10.1111/j.1365-2125.1980.tb01726.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  30 in total

1.  Dosage of theophylline in bronchial asthma.

Authors:  K M Piafsky; R I Ogilvie
Journal:  N Engl J Med       Date:  1975-06-05       Impact factor: 91.245

2.  Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking.

Authors:  R E Vestal; A H Norris; J D Tobin; B H Cohen; N W Shock; R Andres
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

3.  Pharmacokinetics in the elderly.

Authors:  E J Triggs; R L Nation; A Long; J J Ashley
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

4.  Effect of smoking on theophylline disposition.

Authors:  S N Hunt; W J Jusko; A M Yurchak
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

Review 5.  Age-dependent effects in enzyme induction--a biochemical expression of aging.

Authors:  R C Adelman
Journal:  Exp Gerontol       Date:  1971-02-01       Impact factor: 4.032

6.  Effect of phenobarbital on electron transport system, oxidation and reduction of drugs in liver microsomes of rats of different age.

Authors:  R Kato; A Takanaka
Journal:  J Biochem       Date:  1968-03       Impact factor: 3.387

7.  Microsomal mixed-function oxidase activity and senescence-I. Hexobarbital sleep time and induction of components of the hepatic microsomal enzyme system in rats of different ages.

Authors:  M B Baird; R J Nicolosi; H R Massie; H V Samis
Journal:  Exp Gerontol       Date:  1975-04       Impact factor: 4.032

Review 8.  Pharmacokinetics in the elderly.

Authors:  J Crooks; K O'Malley; I H Stevenson
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

9.  Theophylline kinetics in acute pulmonary edema.

Authors:  K M Piafsky; D S Sitar; R E Rangno; R I Ogilvie
Journal:  Clin Pharmacol Ther       Date:  1977-03       Impact factor: 6.875

10.  Effect of age and sex on human drug metabolism.

Authors:  K O'Malley; J Crooks; E Duke; I H Stevenson
Journal:  Br Med J       Date:  1971-09-11
View more
  20 in total

Review 1.  Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

Review 2.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

3.  [Pharmacokinetics and pharmacodynamics of theophylline in geriatric patients with multiple diseases].

Authors:  W Mühlberg; D Platt; M Bauer; U Salzner
Journal:  Klin Wochenschr       Date:  1987-07-15

4.  The relationship between theophylline clearance and age in adult life.

Authors:  S H Jackson; A Johnston; R Woollard; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  The effect of age on theophylline clearance in normal subjects.

Authors:  W C Randolph; J J Seaman; B Dickson; K E Peace; W O Frank; M D Young
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

6.  Steady-state pharmacokinetics and effects of a new once-daily, slow-release theophylline capsule preparation in asthma.

Authors:  P E Williams; Y A Alwazir; P A Routledge; I A Campbell
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

7.  Effects of time of dosing and age on intravenous aminophylline pharmacokinetics.

Authors:  A Rodgers; K W Woodhouse; D N Bateman
Journal:  Br J Clin Pharmacol       Date:  1987-03       Impact factor: 4.335

8.  The relationship between clearance of theophylline and age within the adult age range.

Authors:  S H Jackson; J K Wiffen; A Johnston; C A Peverel-Cooper
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 9.  A critique of dosing strategies for beta-2 adrenergic agents and theophylline.

Authors:  J W Jenne
Journal:  Lung       Date:  1981       Impact factor: 2.584

10.  Theophylline pharmacokinetics in advanced age.

Authors:  E J Antal; P A Kramer; S A Mercik; D J Chapron; I R Lawson
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.